PUBLISHER: The Business Research Company | PRODUCT CODE: 2077040
PUBLISHER: The Business Research Company | PRODUCT CODE: 2077040
DNA and genomic profiling kits are specialized collections of reagents, consumables, and assay components developed to examine genetic material and detect specific DNA sequences or variations. These kits support processes such as DNA extraction, amplification, sequencing preparation, and identification of genetic markers with high precision and reproducibility. They play an essential role in enabling accurate genetic analysis and supporting applications that require dependable identification and characterization of genomic information.
The primary product types of DNA and genomic profiling kits include kits, instruments, and software and services. Kits refer to ready-to-use reagent sets designed to extract, amplify, and analyze DNA for genomic profiling applications in research, clinical, and forensic settings. These solutions are based on throughput such as low throughput manual kits, mid throughput semi-automated kits, high throughput automated library preparation kits, single sample rapid testing kits, and batch processing and 96-well format kits and they are various technologies such as short tandem repeat profiling, real-time polymerase chain reaction, next-generation sequencing, and Y-chromosome short tandem repeat analysis. The various applications involved are oncology diagnostics, genetic disorder screening, pharmacogenomics testing, forensic identification, ancestry and consumer genomics, and infectious disease surveillance, and they are used by several end users such as forensic laboratories, clinical and diagnostic laboratories, direct-to-consumer genetic testing companies, academic and research institutes, pharmaceutical and biotechnology companies, and animal laboratories.
Tariffs are affecting the deoxyribonucleic acid (DNA) and genomic profiling kits market by raising the cost of imported sequencing instruments, PCR systems, reagents, and genomic assay consumables required for genetic analysis and diagnostic applications. This is hindering the adoption of advanced genomic testing technologies and increasing operational expenses for laboratories, especially in regions reliant on imported biotechnology equipment such as Asia-Pacific and Latin America. Segments including DNA sequencing instruments, library preparation kits, and bioinformatics software platforms are experiencing the greatest impact due to global supply chain dependencies and escalating component costs. However, tariffs are also driving local manufacturing, regional supplier diversification, and higher investment in domestic biotechnology production capabilities, creating long-term resilience across the market.
The deoxyribonucleic acid (DNA) and genomic profiling kits market research report is one of a series of new reports from The Business Research Company that provides deoxyribonucleic acid (DNA) and genomic profiling kits market statistics, including deoxyribonucleic acid (DNA) and genomic profiling kits industry global market size, regional shares, competitors with a deoxyribonucleic acid (DNA) and genomic profiling kits market share, detailed deoxyribonucleic acid (DNA) and genomic profiling kits market segments, market trends and opportunities, and any further data you may need to thrive in the deoxyribonucleic acid (DNA) and genomic profiling kits industry. This deoxyribonucleic acid (DNA) and genomic profiling kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The deoxyribonucleic acid (DNA) and genomic profiling kits market size has grown rapidly in recent years. It will grow from $1.28 billion in 2025 to $1.41 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to growing demand for genetic disorder screening, increasing adoption of forensic DNA profiling technologies, rising prevalence of cancer diagnostics and precision medicine, expansion of genomic research initiatives globally, technological advancements in PCR and sequencing systems.
The deoxyribonucleic acid (DNA) and genomic profiling kits market size is expected to see rapid growth in the next few years. It will grow to $2.09 billion by 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing investment in personalized medicine development, rising demand for high throughput genomic testing solutions, expanding applications of pharmacogenomics testing, growing integration of bioinformatics and cloud-based genomic analysis, increasing use of genomic profiling in infectious disease surveillance. Major trends in the forecast period include increasing adoption of rapid DNA extraction kits, rising demand for next-generation sequencing library preparation kits, growth in multiplex PCR-based genomic profiling assays, expanding use of mutation detection kits in clinical diagnostics, increasing preference for user-friendly single sample testing kits.
The rising demand for precision and personalized medicine applications is expected to propel the growth of the DNA and genomic profiling kits market going forward. Precision and personalized medicine applications refer to healthcare approaches that utilize individual genetic, environmental, and lifestyle information to guide disease prevention, diagnosis, and treatment strategies. The increasing demand for these applications is driven by the growing burden of cancer and other genetically complex diseases that require targeted therapeutic approaches. The DNA and genomic profiling kits market is supporting this demand by enabling the identification of genetic mutations and biomarkers that assist in precision oncology and individualized treatment decisions. For instance, in January 2024, according to the National Cancer Institute, a US-based government research organization, 2,001,140 new cancer cases were projected in 2024 compared to 1,958,310 cases in 2023, along with 611,720 projected deaths, highlighting an increasing need for genomics-based precision medicine approaches. Therefore, the rising demand for precision and personalized medicine applications is propelling the growth of the DNA and genomic profiling kits market.
Leading companies operating in the DNA and genomic profiling kits market are focusing on next-generation sequencing-based kit innovations, such as integrated library preparation solutions, to increase throughput and reduce per-sample sequencing costs. Integrated library preparation solutions refer to advanced reagent systems that combine DNA fragmentation, adapter ligation, and amplification into a streamlined workflow to reduce processing time, optimize reagent usage, and improve consistency in sequencing preparation. For example, in March 2023, Illumina Inc., a US-based biotechnology company, launched Illumina Complete Long Read Prep, Human. The solution enables both long-read and short-read sequencing on the same platform, which improves workflow efficiency. It also reduces DNA input requirements and supports high accuracy sequencing output, which enhances scalability and lowers overall cost per sample in genomic studies.
In January 2023, QIAGEN, a Germany-based healthcare technology company, acquired Verogen for $150 million. Through this acquisition, QIAGEN seeks to expand its leadership in DNA and genomic profiling by strengthening its next-generation sequencing (NGS)-based forensic testing portfolio and enhancing capabilities in human identification and investigative genomics. Verogen is a US-based healthcare technology company specializing in NGS-based DNA analysis solutions, including genomic profiling kits and workflows used in forensic and human identification applications.
Major companies operating in the deoxyribonucleic acid (dna) and genomic profiling kits market are Thermo Fisher Scientific, Agilent Technologies, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, 10x Genomics Inc., Promega Corporation, Takara Bio Inc., Twist Bioscience Corporation, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macherey-Nagel GmbH & Co. KG, New England Biolabs, OriGene Technologies Inc., Element Biosciences Inc., BGI Tech Solutions Co. Ltd., Omega Bio-tek Inc., Zymo Research Corporation, Bioneer Corporation, ArcherDX Inc., Solis BioDyne, Verogen Inc., Norgen Biotek Corp., iNtRON Biotechnology Inc., Biotium Inc., NimaGen B. V., EpigenDx Inc., GeneAll Biotechnology Co. Ltd., Paragon Genomics Inc.
North America was the largest region in the DNA and genomic profiling kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (DNA) and genomic profiling kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the deoxyribonucleic acid (DNA) and genomic profiling kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The DNA and genomic profiling kits market consists of sales of DNA extraction kits, genomic DNA isolation kits, polymerase chain reaction kits, quantitative polymerase chain reaction kits, next-generation sequencing library preparation kits, genotyping kits, DNA amplification reagents, DNA quantification kits, microarray kits, and forensic DNA profiling kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Deoxyribonucleic Acid (DNA) And Genomic Profiling Kits Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses deoxyribonucleic acid (dna) and genomic profiling kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for deoxyribonucleic acid (dna) and genomic profiling kits ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The deoxyribonucleic acid (dna) and genomic profiling kits market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.